Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Punarlimab in Acute Gouty Arthritis
NCT07453004Phase 2Recruiting
- Sponsor
- TJ Biopharma
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of plonmarlimab in acute gouty arthritis (3 arms), sponsored by TJ Biopharma. Primary endpoint: Visual Analogue Scale at 72 hours. Started Mar 2026; status: recruiting.
02
Drugs
plonmarlimab
03
Conditions
acute gouty arthritis
Beyond the preview
Go deeper on NCT07453004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07453004.